相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12
Yun-Gyoo Lee et al.
CANCER RESEARCH AND TREATMENT (2021)
On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy
Pablo Nenclares et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis
Yupeng Guan et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2020)
The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis
Gregory E. Idos et al.
SCIENTIFIC REPORTS (2020)
Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patients
Takashi Matsuki et al.
CANCER MEDICINE (2020)
Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Breast Cancer Patients: A Systematic Review
Ileana Corbeau et al.
CANCERS (2020)
Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis
Na Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Predictive value of peripheral lymphocyte counts for immune checkpoint inhibitor efficacy in advanced head and neck squamous cell carcinoma
Jong Chul Park et al.
MOLECULAR AND CLINICAL ONCOLOGY (2020)
Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals
Wanying Guo et al.
CANCER MEDICINE (2019)
Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis
Giovanni Pirozzolo et al.
JOURNAL OF THORACIC DISEASE (2019)
Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancer
Arsela Prelaj et al.
EUROPEAN JOURNAL OF CANCER (2019)
Evaluation of the prognostic role of platelet-lymphocyte ratio in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
Huilin Xu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O'Donnell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer
Rachel Howard et al.
SCIENTIFIC REPORTS (2019)
Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: A systematic review and meta-analysis
Marco A. Mascarella et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)
Platelet count and platelet-lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: Meta-analysis
Yukinori Takenaka et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)
Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: A meta-analysis
Qiaoyun Tan et al.
THORACIC CANCER (2018)
Role of platelets and platelet receptors in cancer metastasis
Martin Schlesinger
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis
Jinan Guo et al.
INTERNATIONAL JOURNAL OF SURGERY (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
The full blood count as a biomarker of outcome and toxicity in ipilimumab-treated cutaneous metastatic melanoma
Leila Khoja et al.
CANCER MEDICINE (2016)
The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis
Ilaria Lucca et al.
EUROPEAN UROLOGY FOCUS (2016)
Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells
Renan Orellana et al.
BMC CANCER (2015)
Inflammation and cancer: advances and new agents
Shanthini M. Crusz et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
The Association of Platelet Count with Clinicopathological Significance and Prognosis in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
Liangyou Gu et al.
PLOS ONE (2015)
Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy
Hailong Jin et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
Eran Elinav et al.
NATURE REVIEWS CANCER (2013)
Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology
Claudia A. Dumitru et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
W. Chua et al.
BRITISH JOURNAL OF CANCER (2011)
Tumor-Associated Neutrophils: New Targets for Cancer Therapy
Alyssa D. Gregory et al.
CANCER RESEARCH (2011)
Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation
Claudia A. Dumitru et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe
Bharat B. Aggarwal et al.
CLINICAL CANCER RESEARCH (2009)
Tumour necrosis factor α:: a potential target for the therapy of solid tumours
PW Szlosarek et al.
LANCET ONCOLOGY (2003)
分享论文
